Two-hour insulinemia after oral glucose overload and women at risk of pregnancy-induced hypertensive disorders

References

• Metzger BE, Coustan DR. Summary and recommendations of the Fourth International Workshop-Conference on Gestational Diabetes Mellitus. The Organizing Committee. Diabetes Care 1998;21:B161–7
   PubMed Web of Science ®Google Scholar
• Harris M, ed. National diabetes data group. Diabetes in America. 2nd ed. Bethesda: National Institutes of Health; 1995
   Google Scholar
• Rowan JA, Gao W, Hague WM, McIntyre HD. Glycemia and its relationship to outcomes in the metformin in gestational diabetes trial. Diabetes Care 2010;33:9–16
   PubMed Web of Science ®Google Scholar
• Sermer M, Naylor CD, Farine D, et al. The Toronto Tri-Hospital Gestational Diabetes Project. A preliminary review. Diabetes Care 1998;21:B33–42
   PubMed Web of Science ®Google Scholar
• O'Sullivan JB, Mahan CM. Criteria for the oral glucose tolerance test in pregnancy. Diabetes 1964;13:278–85
   PubMed Web of Science ®Google Scholar
• , HAPO Study Cooperative Research GroupMetzger BE, Lowe LP, Dyer AR, et al. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 2008;358:1991–2002
   PubMed Web of Science ®Google Scholar
• Lapolla A, Dalfrà MG, Ragazzi E, et al. New International Association of the Diabetes and Pregnancy Study Groups (IADPSG) recommendations for diagnosing gestational diabetes compared with former criteria: a retrospective study on pregnancy outcome. Diabet Med 2011;28:1074–7
   PubMed Web of Science ®Google Scholar
• Schmidt MI, Duncan BB, Reichelt AJ, et al.; Brazilian Gestational Diabetes Study Group. Gestational diabetes mellitus diagnosed with a 2-h 75-g oral glucose tolerance test and adverse pregnancy outcomes. Diabetes Care 2001;24:1151–5
   PubMed Web of Science ®Google Scholar
• Wolf M, Sandler L, Muñoz K, et al. First trimester insulin resistance and subsequent preeclampsia: a prospective study. J Clin Endocrinol Metab 2002;87:1563–8
   PubMed Web of Science ®Google Scholar
• Morris RK, Riley RD, Doug M, et al. Diagnostic accuracy of spot urinary protein and albumin to creatinine ratios for detection of significant proteinuria or adverse pregnancy outcome in patients with suspected pre-eclampsia: systematic review and meta-analysis. BMJ 2012;345:e4342 . 1--12
   PubMed Web of Science ®Google Scholar
• Chou E, Suzuma I, Way KJ, et al. Decreased cardiac expression of vascular endothelial growth factor and its receptors in insulin-resistant and diabetic states: a possible explanation for impaired collateral formation in cardiac tissue. Circulation 2002;105:373–9
   PubMed Web of Science ®Google Scholar
• Montagnani M, Ravichandran LV, Chen H, et al. Insulin receptor substrate-1 and phosphoinositide-dependent kinase-1 are required for insulin-stimulated production of nitric oxide in endothelial cells. Mol Endocrinol 2002;16:1931–42
   Google Scholar
• Vicent D, Ilany J, Kondo T, et al. The role of endothelial insulin signaling in the regulation of vascular tone and insulin resistance. J Clin Invest 2003;111:1373–80
   PubMedGoogle Scholar
• Alzamendi A, Del Zotto H, Castrogiovann D, et al. Oral metformin treatment prevents enhanced insulin demand and placental dysfunction in the pregnant rat fed a fructose-rich diet. ISRN Endocrinol 2012;2012:e757913 . 1--8
   Google Scholar
• Kappas NC, Zeng G, Chappell JC, et al. The VEGF receptor Flt-1 spatially modulates Flk-1 signaling and blood vessel branching. J Cell Biol 2008;181:847–58
   PubMed Web of Science ®Google Scholar
• Thadhani R, Ecker JL, Mutter WP, et al. Insulin resistance and alterations in angiogenesis: additive insults that may lead to preeclampsia. Hypertension 2004;43:988–92
   PubMed Web of Science ®Google Scholar
• Brown MA, Lindheimer MD, de Swiet M, et al. The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregnancy 2001;20:IX–XIV
   PubMed Web of Science ®Google Scholar
• Akolekar R, Bower S, Flack N, et al. Prediction of miscarriage and stillbirth at 11--13 weeks and the contribution of chorionic villus sampling. Prenat Diagn 2011;31:38–45
   PubMed Web of Science ®Google Scholar
• Hiett AK, Brown HL, Britton KA. Outcome of infants delivered between 24 and 28 weeks' gestation in women with severe pre-eclampsia. J Matern Fetal Med 2001;10:301–4
   PubMedGoogle Scholar
• Homburg R. Pregnancy complications in PCOS. Best Pract Res Clin Endocrinol Metab 2006;20:281–92
   PubMed Web of Science ®Google Scholar
• Haffner SM, Kennedy E, Gonzalez C, et al. A prospective analysis of the HOMA model. The Mexico City Diabetes Study. Diabetes Care 1996;19:1138–41
   PubMed Web of Science ®Google Scholar
• Azerad E, Lubetzki J, Duprey J, Friedler D. Insulin secretion during glucose perfusion in normal and diabetic persons: attempt at determination of the efficiency coefficient of the insulin-glucose ratio. J Annu Diabetol Hotel Dieu 1969;10:157–77
   Google Scholar
• Zar JH. Biostatistical analysis. Englewood Cliffs: Prentice-Hall; 1974
   Google Scholar
• National Institute for Health and Clinical Excellence. NICE clinical guideline CG63. Diabetes in pregnancy. Management of diabetes and its complications from pre-conception to the postnatal period. London: NICE; 2008
   Google Scholar
• Metzger BE, Coustan DR. Summary and recommendations of the fourth international workshop conference on gestational diabetes mellitus. Diabetes Care 1998;21:B161–7
   PubMed Web of Science ®Google Scholar
• Landon MB, Spong CY, Thom E, et al.; Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal--Fetal Medicine Units Network. A multicenter, randomized trial of treatment for mild gestational diabetes. N Engl J Med 2009;361:1339–48
   PubMed Web of Science ®Google Scholar
• Mamun AA, Callaway LK, O'Callaghan MJ, et al. Associations of maternal pre-pregnancy obesity and excess pregnancy weight gains with adverse pregnancy outcomes and length of hospital stay. BMC Pregnancy Childbirth 2011;11:6 . 1--9
   Google Scholar
• Vohr BR, McGarvey ST, Tucker R. Effects of maternal gestational diabetes on offspring adiposity at 4–7 years of age. Diabetes Care 1999;22:1284–91
   PubMed Web of Science ®Google Scholar
• Black MH, Sacks DA, Xiang AH, Lawrence JM. Clinical outcomes of pregnancies complicated by mild gestational diabetes mellitus differ by combinations of abnormal oral glucose tolerance test values. Diabetes Care 2010;33:2524–30
   PubMed Web of Science ®Google Scholar
• Wolf M, Sandler L, Muñoz K, et al. First trimester insulin resistance and subsequent preeclampsia: a prospective study. J Clin Endocrinol Metab 2002;87:1563–8
   PubMed Web of Science ®Google Scholar
• Catalano PM, Kirwan JP, Haugel-de Mouzon S, King J. Gestational diabetes and insulin resistance: role in short- and long-term implications for mother and fetus. J Nutr 2003;133:1674S–83S
   PubMed Web of Science ®Google Scholar
• Levine RJ, Lam C, Qian C, et al.; CPEP Study Group. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med 2006;355:992–1005
   PubMed Web of Science ®Google Scholar
• Sifakis S, Akolekar R, Kappou D, et al. Maternal serum insulin-like growth factor-I at 11–13 weeks in preeclampsia. Prenat Diagn 2010;30:1026–31
   PubMed Web of Science ®Google Scholar
• Nanda S, Savvidou M, Syngelaki A, et al. Prediction of gestational diabetes mellitus by maternal factors and biomarkers at 11 to 13 weeks. Prenat Diagn 2011;31:135–41
   PubMed Web of Science ®Google Scholar
• Akolekar R, Syngelaki A, Sarquis R, et al. Prediction of early, intermediate and late pre-eclampsia from maternal factors, biophysical and biochemical markers at 11–13 weeks. Prenat Diagn 2011;31:66–74
   PubMed Web of Science ®Google Scholar
• Chou E, Suzuma I, Way KJ, et al. Decreased cardiac expression of vascular endothelial growth factor and its receptors in insulin-resistant and diabetic states: a possible explanation for impaired collateral formation in cardiac tissue. Circulation 2002;105:373–9
   PubMed Web of Science ®Google Scholar
• Vicent D, Ilany J, Kondo T, et al. The role of endothelial insulin signaling in the regulation of vascular tone and insulin resistance. J Clin Invest 2003;111:1373–80
   PubMedGoogle Scholar
• Luft FC. Soluble endoglin (sEng) joins the soluble fms-like tyrosine kinase (sFlt) receptor as a pre-eclampsia molecule. Nephrol Dial Transplant 2006;21:3052–4
   PubMed Web of Science ®Google Scholar
• Silva JC, Fachin DR, Coral ML, Bertini AM. Perinatal impact of the use of metformin and glyburide for the treatment of gestational diabetes mellitus. J Perinat Med 2012;40:225–8
   PubMed Web of Science ®Google Scholar
• Charles B, Norris R, Xiao X, Hague W. Population pharmacokinetics of metformin in late pregnancy. Ther Drug Monit 2006;28:67–72
   PubMed Web of Science ®Google Scholar
• Gandhi P, Bustani R, Madhuvrata P, Farrell T. Introduction of metformin for gestational diabetes mellitus in clinical practice: has it had an impact? Eur J Obstet Gynecol Reprod Biol 2012;160:147–50
   PubMed Web of Science ®Google Scholar